R. Jensen

A Randomized Phase 2 Trial of Bevacizumab with or without Daily Low-Dose Interferon Alfa-2b in Metastatic Malignant Melanoma

Kimberly A. Varker, Jennifer E. Biber, Cheryl Kefauver et al. · Annals of Surgical Oncology · 2007 · 143 citations

Medicine, Oncology, Pharmacotherapy +16

A Phase I Study of Interleukin 12 with Trastuzumab in Patients with Human Epidermal Growth Factor Receptor-2-Overexpressing Malignancies

Robin Parihar, P. Nadella, Adrian Lewis et al. · Clinical Cancer Research · 2004 · 111 citations

Medicine, Oncology, Pharmacology +17

Noncytotoxic suramin as a chemosensitizer in patients with advanced non-small-cell lung cancer: a phase II study

Miguel A. Villalona‐Calero, Gregory A. Otterson, M. Guillaume Wientjes et al. · Annals of Oncology · 2008 · 37 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase I/II trial of non-cytotoxic suramin in combination with weekly paclitaxel in metastatic breast cancer treated with prior taxanes

Maryam B. Lustberg, Shubham Pant, Amy S. Ruppert et al. · Cancer Chemotherapy and Pharmacology · 2012 · 28 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer

Elaine T. Lam, Jessie L.‐S. Au, Gregory A. Otterson et al. · Cancer Chemotherapy and Pharmacology · 2010 · 23 citations · Full text

Medicine, Oncology, Pharmacology +11